ArticleBone marrow transplantation2022

Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells.

Pu Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.